Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1425 Portland Ave
Rochester, NY 14621Phone+1 585-922-4003Fax+1 585-922-5168
Education & Training
- University of RochesterFellowship, Infectious Disease, 1977 - 1979
- University of RochesterResidency, Internal Medicine, 1974 - 1977
- State University of New York Downstate Medical Center College of MedicineClass of 1974
Certifications & Licensure
- NY State Medical License 1976 - 2026
- TX State Medical License 1977 - 1981
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 22 citationsImportation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching HospitalEmil Lesho, Melissa Bronstein, Patrick McGann, Jason Stam, Yoon I. Kwak
Infection Control and Hospital Epidemiology. 2018-01-01 - 187 citationsRespiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.Sara M. Johnson, Beth A. McNally, Ioannis Ioannidis, Emilio Flaño, Michael N. Teng
Plos Pathogens. 2015-12-11 - 85 citationsSerum antibody decay in adults following natural respiratory syncytial virus infection.Ann R. Falsey, Harjot K. Singh, Edward E. Walsh
Journal of Medical Virology. 2006-11-01
Journal Articles
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, Judith Absalon, Kathleen Neuzil, Vanessa Raabe, Philip R Dormitzer, The New England Journal of Medicine
Press Mentions
- Examine Highlights Significance of RSV Vaccination for High-Risk PopulationsOctober 29th, 2024
- RSV Vaccines Effective, but More People Need to Get ThemOctober 28th, 2024
- Novel Antiviral Appears Effective for Severe RSV in Infants, ToddlersSeptember 25th, 2024
- Join now to see all
Grant Support
- Pathogenesis Of RSV Disease In The ElderlyNational Institute Of Allergy And Infectious Diseases2004–2008
- Pathogenesis Of RSV Disease In The ElderlyNational Institute Of Allergy And Infectious Diseases2003
- Epidemiology And Immunology Of RSV In The ElderlyNational Institute Of Allergy And Infectious Diseases1999–2002
- Clinical Import Of Respiratory Syncytial Virus StrainsNational Institute Of Allergy And Infectious Diseases1989–1991
- Antibody In Respiratory Syncytial Virus InfectionNational Institute Of Allergy And Infectious Diseases1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: